Latest / The Vox Markets Podcast
2377: hVIVO Lands Landmark Phase III Trial
hVIVO has been selected to run the world’s first pivotal Phase III human challenge trial in whooping cough, marking a major scientific milestone and its largest study to date. The contract strengthens revenue visibility into 2026–27 while underlining the growing importance of human challenge trials in accelerating vaccine approvals globally.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.